Paul R. Flynn's Insider Trades & SAST Disclosures

Paul R. Flynn's most recent trade in Dexcom Inc was a trade of 3,163 Common Stock done at an average price of $121.9 . Disclosure was reported to the exchange on Dec. 18, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
DexCom
R. Flynn Paul EVP Global Revenue Sale or transfer of securities back to the company at price $ 121.85 per share. 18 Dec 2023 3,163 48,949 (0%) 0% 121.9 385,412 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale of securities on an exchange or to another person at price $ 120.00 per share. 17 Apr 2023 2,781 52,112 (0%) 0% 120 333,720 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale or transfer of securities back to the company at price $ 111.40 per share. 10 Mar 2023 5,724 63,318 (0%) 0% 111.4 637,648 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale or transfer of securities back to the company at price $ 111.40 per share. 10 Mar 2023 5,643 57,675 (0%) 0% 111.4 628,625 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale or transfer of securities back to the company at price $ 111.40 per share. 10 Mar 2023 5,478 69,042 (0%) 0% 111.4 610,244 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale of securities on an exchange or to another person at price $ 106.27 per share. 10 Mar 2023 2,782 54,893 (0%) 0% 106.3 295,643 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2023 18,776 74,520 (0%) 0% 0.0 19 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale of securities on an exchange or to another person at price $ 123.50 per share. 08 Dec 2022 8,988 55,744 (0%) 0% 123.5 1,110,018 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2022 5,297 19,150 (0%) 0% 0.0 5 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale or transfer of securities back to the company at price $ 406.06 per share. 08 Mar 2022 1,114 16,967 (0%) 0% 406.1 452,347 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale or transfer of securities back to the company at price $ 406.06 per share. 08 Mar 2022 1,069 18,081 (0%) 0% 406.1 434,075 Common Stock
DexCom
Paul R. Flynn EVP Global Revenue Sale or transfer of securities back to the company at price $ 406.06 per share. 08 Mar 2022 784 16,183 (0%) 0% 406.1 318,348 Common Stock
DexCom
Paul R. Flynn EVP, Global Revenue Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2021 2,925 13,853 (0%) 0% 0.0 3 Common Stock
DexCom
Paul R. Flynn EVP, Global Revenue Sale of securities on an exchange or to another person at price $ 541.36 per share. 09 Sep 2021 743 11,563 (0%) 0% 541.4 402,230 Common Stock
DexCom
Paul R. Flynn EVP, Global Revenue Sale of securities on an exchange or to another person at price $ 558.33 per share. 09 Sep 2021 626 10,928 (0%) 0% 558.3 349,515 Common Stock
DexCom
Paul R. Flynn EVP, Global Revenue Sale of securities on an exchange or to another person at price $ 541.78 per share. 09 Sep 2021 9 11,554 (0%) 0% 541.8 4,876 Common Stock
DexCom
Paul R. Flynn EVP, Global Revenue Sale of securities on an exchange or to another person at price $ 400.00 per share. 15 Apr 2021 758 12,306 (0%) 0% 400 303,200 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades